AMGN vs. HOLX: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at AMGN and HOLX, comparing key factors like performance, valuation metrics, dividends, and financial strength.
Company Overview
AMGN’s market capitalization of 158.74 billion USD is substantially larger than HOLX’s 14.43 billion USD, indicating a significant difference in their market valuations.
With betas of 0.50 for AMGN and 0.55 for HOLX, both stocks show similar sensitivity to overall market movements.
| Symbol | AMGN | HOLX |
|---|---|---|
| Company Name | Amgen Inc. | Hologic, Inc. |
| Country | US | US |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Medical - Instruments & Supplies |
| CEO | Mr. Robert A. Bradway | Mr. Stephen P. MacMillan |
| Price | 295.22 USD | 64.75 USD |
| Market Cap | 158.74 billion USD | 14.43 billion USD |
| Beta | 0.50 | 0.55 |
| Exchange | NASDAQ | NASDAQ |
| IPO Date | June 17, 1983 | March 1, 1990 |
| ADR | No | No |
Performance Comparison
This chart compares the performance of AMGN and HOLX over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Data is adjusted for dividends and splits.
- AMGN: $10048.33 (0.48%)
- HOLX: $9064.82 (-9.35%)
Valuation Metrics Comparison
This section compares the market valuation of AMGN and HOLX. Key takeaways regarding their valuation, when viewed within their industry context, are presented in the commentary that follows.
- AMGN’s Forward PEG ratio of 7.49 and HOLX’s Forward PEG ratio of 3.32 are both considered very high. For AMGN, this elevated ratio implies its stock price may incorporate highly optimistic growth assumptions that could be challenging to realize. HOLX’s very high PEG also suggests its valuation is quite rich relative to its expected earnings growth, potentially indicating overvaluation.
- AMGN’s Price-to-Book (P/B) ratio of 25.59 is very high. This often indicates that the market values the company significantly above its net asset value, usually reflecting strong profitability, valuable intangible assets (like brand or patents), or high expectations for future growth.
| Symbol | AMGN | HOLX |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | 26.77 | 26.26 |
| Forward PEG Ratio (TTM) | 7.49 | 3.32 |
| Price-to-Sales Ratio (P/S, TTM) | 4.65 | 3.58 |
| Price-to-Book Ratio (P/B, TTM) | 25.59 | 3.17 |
| EV-to-EBITDA (TTM) | 16.75 | 15.26 |
| EV-to-Sales (TTM) | 6.07 | 3.86 |
Dividend Comparison
AMGN provides a 3.14% dividend yield, potentially offering a blend of income and growth, whereas HOLX currently does not pay a dividend, possibly retaining profits to fund operations or growth initiatives.
| Symbol | AMGN | HOLX |
|---|---|---|
| Dividend Yield (TTM) | 3.14% | 0.00% |
Financial Strength Metrics Comparison
This section evaluates the financial strength of AMGN and HOLX. Noteworthy observations on their financial resilience, considered from an industry perspective, are detailed in the points that follow.
- AMGN’s Debt-to-Equity (D/E) ratio of 9.24 is very high. This indicates that the company is significantly financed by debt, which can amplify returns but also substantially increases its financial risk profile and vulnerability to earnings fluctuations.
| Symbol | AMGN | HOLX |
|---|---|---|
| Current Ratio (TTM) | 1.17 | 3.24 |
| Quick Ratio (TTM) | 0.88 | 2.52 |
| Debt-to-Equity Ratio (TTM) | 9.24 | 0.55 |
| Debt-to-Asset Ratio (TTM) | 0.64 | 0.30 |
| Net Debt-to-EBITDA Ratio (TTM) | 3.92 | 1.08 |
| Interest Coverage Ratio (TTM) | 3.19 | 5.81 |